Final Prospectus Filed for Highly Dilutive Resale of 13.8M Shares by Selling Stockholder
KARX sits 41% above its 52-week low of $0.275.
Summary
Karbon-X Corp. filed the final prospectus for the resale of up to 13.8 million shares by Mast Hill Fund, L.P., stemming from convertible notes with highly dilutive "death spiral" conversion terms.
Key Events · Financing and Capital Events · KARX
-
Finalizes Resale Offering
Prospectus filed for the resale of up to 13.8 million common shares by Mast Hill Fund, L.P., following the S-1 registration on February 2, 2026.
-
Highly Dilutive Terms
Shares are convertible from notes at 85% of the lowest 10-day VWAP, with a $0.01 minimum, indicating significant potential dilution for existing shareholders.
-
No Direct Company Proceeds
Karbon-X Corp. will not receive any proceeds from the sale of shares by the selling stockholder.
-
Substantial Dilution
The offering represents approximately 15.7% of the company's current outstanding shares.
Analysis · KARX · Industrial Applications And Services
This 424B3 filing finalizes the terms for the resale of a substantial block of shares by a selling stockholder, Mast Hill Fund, L.P., following the S-1 registration filed on February 2, 2026. The offering involves up to 13.8 million shares, representing approximately 15.7% of the company's current outstanding common stock. The shares originate from convertible promissory notes and warrants with extremely unfavorable conversion terms, specifically 85% of the lowest volume-weighted average price (VWAP) during the ten trading days preceding conversion, with a minimum of $0.01 per share. This "death spiral" financing mechanism is highly dilutive for existing shareholders and is explicitly identified as a risk factor by the company itself, which states that the market price of its common stock may decline due to these conversions. The company will not receive any direct proceeds from the resale of these shares, although it has received initial tranches from the underlying convertible notes. This significant potential dilution, coupled with the company's previously disclosed "going concern" warning from its 10-Q on January 20, 2026, underscores the precarious financial position and the negative implications for shareholder value.
At the time of this filing, KARX was trading at $0.39 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $34.1M. The 52-week trading range was $0.28 to $2.50. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.